Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Pfizer claims 5-HT1 agonists and antagonists for CNS disorders

May 17, 1996

FO-2546F: ACAT inhibitor from Albophoma yamanashiensis

May 17, 1996

SmithKline Beecham claims hemoregulatory agents

May 17, 1996

Mitsui Toatsu claims antitumor trifluorothymidine derivatives

May 17, 1996

Human Genome Sciences claims chemokine beta-9 polypeptides and their antagonists

May 17, 1996

Platinum complexes claimed by Nippon Kayaku

May 17, 1996

Novel antiarthritics claimed by Procter & Gamble

May 17, 1996

British Biotech reveals metalloproteinase inhibitors

May 17, 1996

COX-2 inhibitors claimed by Searle

May 17, 1996

Triazole antifungals reported by Tanabe

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...